TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.
about
Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in GuangxiALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.
P2860
TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@en
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@nl
type
label
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@en
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@nl
prefLabel
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@en
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@nl
P2093
P2860
P1433
P1476
TP53 immunohistochemical expre ...... evidence from a meta-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-013-1228-7
P577
2014-02-01T00:00:00Z